doi: 10.1016/j.chom.2012.03.008, 27 KlionskyD
In clinical trials, retatrutide side effects included gastrointestinal problems like nausea, diarrhea, vomiting and constipation
The rules on peptides are in flux, and they might soon change to the point that DSIP, and other peptides on the restricted list, becomes more readily available
Additionally, 70-80% of semaglutide users lost more than 5% of body weight
Clinical trials of Wegovy purposely excluded people with recent suicidal thoughts, a history of suicide attempts, schizophrenia, bipolar disorder and those who had been depressed within the past two years
J Am Coll Surg